SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-033741
Filing Date
2018-07-26
Accepted
2018-07-26 21:10:12
Documents
1
Period of Report
2018-07-24

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3861
  Complete submission text file 0001140361-18-033741.txt   5270
Mailing Address C/O BIOENVISION, INC. 345 PARK AVENUE, 41ST. FLOOR NEW YORK NY 10154
Business Address
Scibetta James S (Reporting) CIK: 0001383242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 18973054

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations